Suzhou HepaThera Biotech Co., Ltd.

Private

ShanghaiHealthcare & Life Scienceshttps://hepathera.com/

Last Round

Pre Seed

Feb 1, 2023

Total Funding Raised

$14.7M

Company Overview

Suzhou HepaThera Biotech Co., Ltd. is a biotechnology company that develops innovative therapies for the treatment of liver diseases, including hepatitis B and D.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalliver diseasedrug discoverymetabolic disordersdrug developmentclinical trialsR&Dsmall moleculebiotechhepatologydrug licensingtherapeutic assetsclinical-stagepharma pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Suzhou HepaThera Biotech Co., Ltd. Comparables

Compare Suzhou HepaThera Biotech Co., Ltd. with similar companies based on industry and business-model similarity.

Suzhou HepaThera Biotech Co., Ltd. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Shanghai Hepu Pharmaceutical Co., Ltd.	82%
Ascletis Pharma Inc.	76%
HighTide Therapeutics Inc	73%

View all Comparables

Suzhou HepaThera Biotech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Pre Seed	Feb 1, 2023
Seed	Nov 1, 2021

View all Funding Rounds

Suzhou HepaThera Biotech Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Suzhou HepaThera Biotech Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Suzhou HepaThera Biotech Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai

Year Founded2021

Last FundingFeb 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?